Seeing Is Believing
Currently out of the existing stock ratings of Mike Matson, 680 are a BUY (84.05%), 125 are a HOLD (15.45%), 4 are a SELL (0.49%).
Analyst Mike Matson, currently employed at NEEDHAM, carries an average stock price target met ratio of 59.37% that have a potential upside of 26.88% achieved within 272 days.
Mike Matson’s has documented 1,428 price targets and ratings displayed on 44 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on BSX, Boston Scientific Corp at 16-Oct-2025.
Analyst best performing recommendations are on PSNL (PERSONALIS).
The best stock recommendation documented was for PSNL (PERSONALIS) at 6/21/2024. The price target of $3.5 was fulfilled within 28 days with a profit of $2.28 (186.89%) receiving and performance score of 66.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$45
$7.84 (21.10%)
$44
2 months 24 days ago
(29-Jul-2025)
13/33 (39.39%)
$9.87 (28.10%)
184
Buy
$58
$20.84 (56.08%)
$40
5 months 24 days ago
(29-Apr-2025)
5/13 (38.46%)
$28.09 (93.92%)
302
Buy
$52
$14.84 (39.94%)
$66
6 months 26 days ago
(27-Mar-2025)
2/17 (11.76%)
$20.17 (63.37%)
36
Buy
$45
$7.84 (21.10%)
$36
8 months 11 days ago
(12-Feb-2025)
10/11 (90.91%)
$5.41 (13.67%)
113
Buy
$48
$10.84 (29.17%)
$26
8 months 11 days ago
(12-Feb-2025)
10/12 (83.33%)
$8.41 (21.24%)
105
Which stock is Mike Matson is most bullish on?
Which stock is Mike Matson is most reserved on?
What Year was the first public recommendation made by Mike Matson?